Results 151 to 160 of about 23,919 (200)
Combination of Ceftazidime-Avibactam and Aztreonam Effectively Treated Post-Cardiac Surgery Pneumonia Caused by Hypervirulent KPC- and NDM-Producing <i>Klebsiella pneumoniae</i>: A Case Report. [PDF]
Infect Drug ResistWei Q +6 more
europepmc +1 more source
Analysis of a simple disk diffusion method to evaluate ceftazidime-avibactam/aztreonam combination synergism against New Delhi metallo-beta-lactamase-producing clinical isolates. [PDF]
Access MicrobiolRajan R +4 more
europepmc +1 more source
Severe Hyponatremia in a Septic Patient With Bronchopneumonia: A Case Report. [PDF]
CureusKakkar N.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Infection Control & Hospital Epidemiology, 1990
Aztreonam, the first licensed monobactam in the United States, is a β-lactam antimicrobial agent with a unique structure and in vitro spectrum of activity. The drug is active only against gram-negative aerobic bacteria in vitro, thus resembling the spectrum of aminoglycosides, but displays the safety profile typical of β-lactam agents.
A R, Tunkel, W M, Scheld
+8 more sources
Aztreonam, the first licensed monobactam in the United States, is a β-lactam antimicrobial agent with a unique structure and in vitro spectrum of activity. The drug is active only against gram-negative aerobic bacteria in vitro, thus resembling the spectrum of aminoglycosides, but displays the safety profile typical of β-lactam agents.
A R, Tunkel, W M, Scheld
+8 more sources